{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.72 vs. cons $0.70",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.11B vs. cons $1.09B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~4.1% vs. cons 3.6%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted diluted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.95 midpoint vs. cons $2.96 (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Q3 adjusted diluted EPS outlook",
      "prediction": "LOWER",
      "answer": "guide ~$0.70 vs. cons $0.73 (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 core revenue growth outlook",
      "prediction": "UNCHANGED",
      "answer": "guide ~2.8% midpoint vs. cons 2.8% (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.0,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 beat of ~$0.02 EPS and ~$0.02B revenue is likely outweighed by FY26 EPS guidance held near a ~$2.95 midpoint and a Q3 EPS setup of ~$0.70 versus ~$0.73 consensus; that out-period shortfall implies downward estimate revisions despite solid organic growth.",
  "day5_confidence": "MEDIUM"
}